Assessing the Impact of a Safe and Equitable Biosimilar Policy in ...

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher: None

ABOUT BOOK

... life - saving medicines . Today , biopharmaceutical manufac- turers enjoy monopoly positions . Today , unlike traditional pharmaceuticals , no com- petition is created in the marketplace once a patent has expired on a brand name ...

© 2024 NPMCN, All Rights Reserved
Powered by: